Navigation Links
Champions Biotechnology, Inc.'s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference
Date:2/5/2009

Waldorf Astoria Hotel in New York City, Tuesday, February 10th 2009

ARLINGTON, Va., Feb. 5 /PRNewswire-FirstCall/ -- Doug Burkett, PhD, Principal Executive Officer of Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, will present at BIO CEO & Investor Conference Tuesday, February 10, 2009 at the Waldorf Astoria Hotel in New York City. The presentation will be held at 10:30am in the Jade Room.

Dr. Burkett's presentation will focus on Champions' developing pipeline of value enhanced oncology drugs. Dr. Burkett will also highlight the company's Biomerk Tumorgraft(TM) platform, which pre-qualifies its pipeline to be those oncology drug candidates that offer the best opportunity, either singularly or in combination, for clinical success.

About Champions Biotechnology, Inc.

Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs. The Company's Preclinical Platform is a novel approach based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments (Biomerk Tumorgrafts(TM)) in a manner that preserves the biological characteristics of the original human tumor. Early studies suggest that unlike traditional xenografts these Tumorgrafts closely reflect human cancer biology and their response to drugs is predictive of clinical outcomes in cancer patients.

Champions Biotechnology leverages its preclinical platform to evaluate drug candidates and to develop a portfolio of novel therapeutic candidates through pre-clinical trials. As drugs progress through this early stage of development, the Company plans to sell, partner or license them to pharmaceutical and/or biotechnology companies, as appropriate. The Company also offers its predictive preclinical platform and tumor specific data to physicians for personalized patient care and to companies for evaluation of oncology drugs in models that integrate prognostic testing with biomarker discovery.

Forward-Looking Statements

This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties. Champions Biotechnology generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Biotechnology's Form 10-KSB for the fiscal year ended April 30, 2008 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Biotechnology's future results, levels of activity, performance or achievements, including but not limited to the achievement of milestones as required to realize the royalties referenced above, may not meet these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Biotechnology's expectations, except as required by law.


'/>"/>
SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Land Rover Americas Polo Cup Team Plays in USPA World Snow Polo Championships, Aspen, Colorado
2. Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship
3. Blue Cross and Blue Shield of Florida Champions Health Care Education and Access for Floridas Hispanic Community
4. Clay Aikens Bubel/Aiken Foundation Raises Over $500,000 to Benefit Children With Disabilities at Gala Honoring the 2008 Champions Of Change
5. Mike Bridges Takes Home Four Gold Medals at IPF Masters World Powerlifting Championships; Says NutraCeas RiSolubles(R) is an Essential Part of his Training Regimen
6. Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer
7. 2008 Champions of Health Award Winners Announced
8. Champions of Health Awards Nomination Deadline Extended to Aug. 8
9. Nominations Accepted for 2008 Champions of Health Awards
10. Defending Champions Andy Potts and Leanda Cave Win 28th Annual Accenture Escape From Alcatraz(TM) Triathlon Sunday, June 8
11. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior ... the Dallas area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ ... Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... ... undergoing major cosmetic surgery can now take advantage of a cosmetic procedure known ... skin rejuvenation treatment that reduces the appearance of age spots, fine lines, ...
(Date:12/4/2016)... ... 04, 2016 , ... Responsible dental care hinges on regular brushing of the ... results. This important necessity inspired an inventor from Las Vegas, Nev., to design the ... people break or avoid bad techniques of brushing the teeth in order to prevent ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... office, will speak at the American Conference Institute’s 21st Drug & Medical Device ... a Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec 2, 2016 Research and ... Database" newsletter to their offering. ... , , R&D ... Merie Publishing,s proprietary R&D Drug Pipeline Database provides 24/7 online access ... drugs on the market and on investigational drug candidates in research ...
(Date:12/2/2016)... -- bioLytical Laboratories, un líder mundial en test rápidos de enfermedades ... Test , a los miembros de la Kenya Pharmaceutical Association. ... ... HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton Health ...
(Date:12/2/2016)... GARDENS, N.Y. , Dec. 2, 2016  LifeVac, ... will be included in the Emergency Response Training and ... are very excited to have LifeVac become part of ... Lih , Founder and CEO of LifeVac. "Having an ... LifeVac safely and effectively will help leverage our efforts ...
Breaking Medicine Technology: